Table 2 Patient demographic and clinical characteristics
From: A single centre retrospective study of systemic reactions to subcutaneous immunotherapy
Characteristic | Patients with systemic reaction |
|---|---|
Median age—yr | 34 |
Age range—yr | 8–60 |
Male patients, n (%) | 19 (68.9) |
Angiotensin converting enzyme inhibitor or angiotensin receptor blocker use, n (%) | 0 (0) |
Beta-blocker use, n (%) | 0 (0) |
Asthma, n (%) | 11 (39.3) |
Grade 1 reaction, n (%) | 8 (28.6) |
Grade 2 reaction, n (%) | 9 (32.1) |
Grade 3 reaction, n (%) | 8 (28.6) |
Grade 4 reaction, n (%) | 3 (10.7) |